In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Leading industry insight at your fingertips

Video, audio, and proprietary data sets bring our articles and analyses to life.

Numerous search filters allow for precise content targeting, and articles and searches can be saved and shared with one-click

Set custom email alerts on any topic or search criteria so you never miss what you need to know most.




Phone (US): +1 212-520-2765
Phone (UK & Europe): +44 (0) 20 7017-4191

Subscribe today and get access to:

  • The latest on biopharma, medtech and diagnostic strategies with insights on how to grow product revenues.
  • The most relevant deal-making, regulatory, commercial and financial news and analysis.
  • Feature articles on hot topics in R&D, investment technology, clinical trials, deal-making in depth, M&A activity and business developments.
  • In-depth profiles of leading-edge companies assessing new trends and technologies.
  • Competitor product launches and industry wide drug strategy updates.
  • Customize and deepen your knowledge of commercial & competitive environment via custom email alerts to get the full picture.
  • My View, a custom home page that follows your topics of interest.
  • Refine your search so you just see news/analysis/opinion by media type (listen/watch/read)
  • Scan headlines to be up-to-date on the latest, and tailor the service to your specific needs with refined targeted searches, and custom email alerts and RSS feeds so you never miss a development.
  • “Ask the Analyst” exclusive client service to find out more about market access topics, developments, or trends to support presentations, proposals, or business critical decisions where your credibility is on the line.